NeuroPace, Inc. (NPCE)
Implants a brain device that detects and stops seizures before they happen.
$15.31+0.00%Healthcare
StockGlow Score
Leaning Bullish
BearishBullish
1 year ago+70.3%
The outlook
NPCE is trading near the middle of its 52-week range with a Strong Buy consensus from analysts. The average price target sits roughly 32% above the current price, though the stock shows mixed momentum against its moving averages. Overall sentiment leans bullish based on analyst ratings and valuation positioning.
What’s behind the score
Analyst consensusStrong Buy — 1.1 avg of 9 analysts
Price trendMixed vs its moving averages
52-week range64% of the way from its 52-week low to high
Price targetAvg target +32% vs current price
Analyst price target
~12-month · 9 analysts$20.22average target+32.1% vs now
Now $15.31
Low $18.00High $22.00
Published targets from Wall Street analysts (public data) — what analysts expect over roughly a year. This is not a StockGlow forecast and not a recommendation. Analyst targets are frequently wrong.
Market cap
$522.0M
52-wk high
$19.60
52-wk low
$7.56
50-day avg
$16.08
200-day avg
$15.03
Trailing P/E
—